Captisol Molecule (IMAGE)

University of Kansas

Captisol Molecule

Caption

Rendering of the molecular structure of Captisol, the solubilizer invented at the University of Kansas, which allows remdesivir to be administered to the patient. Remdesivir was recently authorized under an emergency-use protocol to treat patients with COVID-19.

Credit

Valentino Stella, University Distinguished Professor Emeritus at KU

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.